DOCSLIB.ORG

People Behind Discovery Annual Review the Medical Research Council Is the UK’S Leading Publicly Funded Biomedical Research Organisation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
People Behind Discovery Annual Review the Medical Research Council Is the UK’S Leading Publicly Funded Biomedical Research Organisation 06/07 People behind discovery Annual Review The Medical Research Council is the UK’s leading publicly funded biomedical research organisation. Our mission is to: • Encourage and support high-quality research with the aim of improving human health. • Produce skilled researchers, and to advance and disseminate knowledge and technology to improve the quality of life and economic competitiveness in the UK. • Promote dialogue with the public about medical research. 01 Vision & hearing page 4 02 Neurobiology & neurodegeneration page 6 03 Mental illness & behavioural disorders page 10 04 Genetic diseases page 14 05 Cancer page 18 06 Heart disease & stroke page 22 07 Obesity & diabetes page 26 08 Infections & the immune system page 30 09 Public health page 34 10 Turning research into healthcare page 38 Supporting careers in medical research For almost a century, the Medical Research Council (MRC) has employed and funded people who’ve made pioneering discoveries and improved the health of millions. Together these scientists, clinicians, support staff, technicians, nurses, business managers, administrators, engineers and countless other people have created an unsurpassed catalogue of achievement. Today, we employ more than 4,000 staff in our own research institutions and support about another 3,300 researchers and students on grants. The MRC is an employer as well as a research funder. Some of our researchers start their careers on studentships or fellowships with the MRC. Others are supported on grants or in our units for a time before moving on. Many spend their whole career with the MRC. Our scientists work in many different research environments. These include hospitals, universities, medical schools, the biotechnology, diagnostics and pharmaceutical industries and MRC units, institutes and centres. The MRC also supports people who later in their careers might help move science into policy and practice. In this year’s Annual Review we feature some of the discoveries made by MRC scientists during the past year. We also introduce you to some of the people behind these discoveries. Each of these people has a story to tell about the work they do and the career path they’ve taken. For instance, Viv Moffat at the University of Edinburgh, who previously worked as a mental health nurse, has just finished her PhD. She is contributing to a decade-long study of brain imaging and schizophrenia. Dr Rachel Batterham is an obesity and diabetes specialist, who spends much of her time undertaking research to try to find new ways to help the patients she treats. Professor Steve Brown runs the MRC’s Mammalian Genetics Unit at Harwell. He is researching the genetic causes of deafness. And Professor Jeanne Bell started her career in anatomy but then moved to pathology and neuropathology. For more than two decades she has been researching the effects on the brain of HIV and its treatment. The wide range of training opportunities available to scientists means careers can be forged in various ways. For instance, the MRC Career Development Fellowship scheme provides early career post-doctoral scientists with training positions within MRC research units to help establish themselves as research scientists. Our Clinician Scientist Fellowship scheme gives up to five years of funding for post-doctoral scientists in universities. We offer training awards in particular areas where there are national shortages, such as biostatistics, stem cell biology and public health. We also run studentships, aimed at supporting post-graduate students, in collaboration with other research funders, universities and industry. This is just a snapshot of the MRC’s dedicated training schemes. For more information about these programmes and others, visit www.mrc.ac.uk/careers. continued… … it’s important to develop scientists beyond their research … it’s less about a job for life and more about providing opportunities, skills and knowledge for life. MRC Annual Review 2006/07 1 continued … The MRC doesn’t just support scientific careers – we also have hundreds of people sustaining our research, working in administration, business, intellectual property and the many other roles needed to facilitate the best medical research. For example, over the past year we have increased training opportunities and expanded the national qualifications available for our animal technicians. We have also completed a trial training a group of staff to diploma level in management skills. But we don’t work in isolation. We achieve much more when we work closely with other organisations to tailor the finest range of training and development opportunities available. The Department of Health (www.dh.gov.uk), the UK Clinical Research Collaboration (www.ukcrc.org), the Research Councils UK’s Research Careers Diversity Unit (www.rcuk.ac.uk/rescareer/rcdu), the other research councils (www.rcuk.ac.uk), universities and charities such as the Wellcome Trust (www.wellcome.ac.uk) are just some of the organisations we work with to make this happen. As the UK landscape for medical research changes, the MRC is well placed to continue to foster the best scientists and the best science. The introduction of an Office for Strategic Coordination of Health Research (OSCHR) to oversee medical research in the UK means that, in the future, the MRC will work even more closely with the Department of Health’s National Institute for Health Research (www.nihr.ac.uk) and with other medical research organisations and industry. These changes will present more opportunities for training the next generation of medical researchers. The MRC realises that it’s important to develop scientists beyond their research. These days, it’s less about a job for life and more about providing opportunities, skills and knowledge for life. What we do wouldn’t be possible without the people who make up the MRC. We hope that you’ll enjoy reading the stories of just a few of these people and finding out about some of our scientific achievements from the past year. Welcome Professor Colin Blakemore, MRC Chief Executive In any career, nothing is more important than the people who teach you and the environment in which you learn. In my own career, I was very lucky in both respects. I was the first person in my family to go to school beyond the age of 15. My parents knew nothing about higher education but were extraordinarily encouraging. I passed my 11-plus, went to an excellent grammar school in Coventry and won a State Scholarship to study medicine at Cambridge, which covered all my costs. The academic ethos of Cambridge was intoxicating for me, from a working-class background, unsure what I wanted to do with my life. It was the early sixties, just 10 years after the discovery of the structure of DNA. The realisation that, just a stone’s throw from where I was studying, Crick and Watson had revolutionised our understanding of life had a huge impact on me. I won a Harkness Fellowship to study in the States after I graduated from Cambridge, and went to the University of California, Berkeley, to work with Horace Barlow, great-great-grandson of Darwin and one of the most influential neurophysiologists of the last century. Again, I found myself in an extraordinary environment. It wasn’t so much the quality of the facilities – techniques were pretty simple then. It was the passion and support of the others in the lab – not just the leaders, but the postdocs and the other graduate students, all learning from each other through the curious mixture of tedium and exhilaration that makes research such a remarkable career. Luck is important, I must admit. And I was very lucky. My research was a goldmine: I finished my PhD in record time and was offered a tenure-track position at Cambridge at the age of 23. And I picked up my first grant from the MRC just a year later. That enabled me to set up my own lab, but I also benefited from collaboration with Fergus Campbell, Roger Carpenter and many others in Cambridge. I found myself in the middle of a little scientific revolution – the birth of neuroscience as a discipline in its own right. With a lot of support from the MRC over the years, I never looked back. I sometimes regret not completing a clinical degree and not having the experience of a postdoctoral appointment. There were disappointments and challenges along the way (not least the 13 years for which I was targeted by animal rights extremists). But the joy of discovery, and the camaraderie of my research group, with young people from around the world, compensated for any problems. Things are different today. Training has to be longer. Jobs are harder to find. Competition is more extreme. But medical research is still a wonderful career – a chance to comprehend things that no- one has ever understood before and to be part of a worldwide effort to improve the lives of others. MRC Annual Review 2006/07 3 Name Robin Ali Name Robert MacLaren Education Undergraduate and PhD Born 14 November 1966 in Epsom, Surrey at University College London Education MB ChB, University of Edinburgh; Awards 2001 Sir Jules Thorn Award DPhil, University of Oxford for Biomedical Research Family Married with three children: William Current job title Professor of Human (3), Imogen (2) and Edward (6 months) Molecular Genetics Awards 2007 King James IV Professorship Time in current position 5 years of Surgery, 2005 Oxford Ophthalmological Field of research Development of Congress Founder’s Cup and Medal, 2005 gene and cell therapies for the Royal Society of Medicine Prize Meeting treatment of eye disease in Ophthalmology Ambition To make a real difference Current job title Clinician Scientist and to patients with visual impairment Honorary Consultant Career highlight Helping perform the world’s first retinal gene therapy treatment Blind mice see again Professor Robin Ali and Dr Robert MacLaren (see profiles) at the Institute of Ophthalmology/Moorfields Eye Hospital 01 Vision & hearing in London have overcome a major hurdle to restore vision in blind mice.
Load more

Recommended publications
  • Calling Time the Nation’S Drinking As a Major Health Issue
    Calling Time The Nation’s drinking as a major health issue 12 250 10 200 8 150 6 100 4 50 to income Price relative 2 Litres of alcohol per person aged 15+Litres 0 0 1960 1964 1968 1970 1976 1980 1984 1988 1992 1996 2000 A report from the Academy of Medical Sciences With support from March 2004 The independent Academy of Medical Sciences promotes advances in medical science and public health and campaigns to ensure these are translated as quickly as possible into benefits for society. The Academy’s 750 Fellows are the United Kingdom’s leading medical scientists from hospitals, academia, industry and the public service. The aims of the Academy are to: • give national and international leadership in the medical sciences; • promote the application of research to the practice of medicine and to the advancement of human health and welfare; • promote the aims and ethos of medical sciences with particular emphasis on excellence in research and training; • enhance public understanding of the medical sciences and their impact on society; • assess and advise on issues of medical science of public concern. The Academy of Medical Sciences was established in 1998 following the recommendations of a working group chaired by Sir Michael Atiyah, Past President of the Royal Society. There is an elected Council of 22 Fellows that includes the five Officers of the Academy: President Sir Keith Peters, FRS, PMedSci Vice-President (Clinical) Lord Turnberg, FMedSci Vice-President (Non-clinical) Sir John Skehel, FRS, FMedSci Treasurer Sir Colin Dollery, FMedSci Registrar Professor Patrick Vallance, FMedSci The Academy is a registered charity and a company limited by guarantee.
    [Show full text]
  • Science & Policy Meeting Jennifer Lippincott-Schwartz Science in The
    SUMMER 2014 ISSUE 27 encounters page 9 Science in the desert EMBO | EMBL Anniversary Science & Policy Meeting pageS 2 – 3 ANNIVERSARY TH page 8 Interview Jennifer E M B O 50 Lippincott-Schwartz H ©NI Membership expansion EMBO News New funding for senior postdoctoral In perspective Georgina Ferry’s enlarges its membership into evolution, researchers. EMBO Advanced Fellowships book tells the story of the growth and ecology and neurosciences on the offer an additional two years of financial expansion of EMBO since 1964. occasion of its 50th anniversary. support to former and current EMBO Fellows. PAGES 4 – 6 PAGE 11 PAGES 16 www.embo.org HIGHLIGHTS FROM THE EMBO|EMBL ANNIVERSARY SCIENCE AND POLICY MEETING transmissible cancer: the Tasmanian devil facial Science meets policy and politics tumour disease and the canine transmissible venereal tumour. After a ceremony to unveil the 2014 marks the 50th anniversary of EMBO, the 45th anniversary of the ScienceTree (see box), an oak tree planted in soil European Molecular Biology Conference (EMBC), the organization of obtained from countries throughout the European member states who fund EMBO, and the 40th anniversary of the European Union to symbolize the importance of European integration, representatives from the govern- Molecular Biology Laboratory (EMBL). EMBO, EMBC, and EMBL recently ments of France, Luxembourg, Malta, Spain combined their efforts to put together a joint event at the EMBL Advanced and Switzerland took part in a panel discussion Training Centre in Heidelberg, Germany, on 2 and 3 July 2014. The moderated by Marja Makarow, Vice President for Research of the Academy of Finland.
    [Show full text]
  • Download PDF Version of Issue 84
    Cambridge Alumni Magazine Issue 84 – Easter 2018 What a snooze fest: why boredom could actually be good for you. Scandi flatpack buildings fit for the Ottoman Emperor. New books, old books, little known books: the summer reading list. Immersive tours of the East; from temples in Varanasi to tea gardens in Kanazawa From India’s Mughal palaces to Japan’s temple gardens, our iti neraries Illustrati on: aquati nt c. 1830 aft er a drawing by Robert Melville Grindlay. across Asia celebrate the cultural achievements of some of the world’s most extraordinary civilisati ons. Explore the Buddhist temples of Varanasi and sail Vietnam’s Perfume River. ‘Every day we got up thinking Interpret the ‘art of the fl oati ng world’ in Kyoto and the exquisite treasures it couldn’t possibly be as good of Ming and Qing Beijing. as the day before, and it was. In all fi ve countries of our Asia programme our expert lecturers enliven Diff erent and wonderful.’ ancient philosophies and dazzling landscapes with their eruditi on and enthusiasm. Expect, equally, high standards of accommodati on and Contact us: privileged access at key sites. +44 (0)20 8742 3355 Our dozen tours in Asia include Sacred India, Kingdoms of the Deccan, Bengal by River, Indian Summer, Ming & Qing Civilisati on, Essenti al China, Japanese marti nrandall.com/asia Gardens, Samarkand & Silk Road Citi es and Vietnam. ATOL 3622 | ABTA Y6050 | AITO 5085 Editor Immersive tours of the East; Mira Katbamna Commissioning editor Steve McGrath from temples in Varanasi to Design and art direction Rob Flanagan University of Cambridge tea gardens in Kanazawa Morven Knowles Cambridge Alumni Magazine Issue 84 Easter 2018 02 INBOX Publisher The University of Cambridge Development & Alumni Relations Campendium 1 Quayside, Bridge Street 30 Cambridge CB5 8AB Tel +44 (0)1223 332288 07 DON’S DIARY Dr Andrew Grant.
    [Show full text]
  • Alzheimers Society Annual Research Review 2017
    Annual 2017/ 2018 Research Review 2 Annual Research Review 2017/2018 Foreword Last year we launched our new strategy – the New Deal on Dementia – with a mission to transform the landscape of dementia forever by boosting research, changing society and offering support to everyone affected by dementia. It’s been brilliant to see our strategy take shape over the last 12 months. The UK Dementia Research Institute, our biggest ever single investment in research, is attracting over 400 world-leading scientists to focus their skills and energy on dementia. A partnership between Alzheimer’s Society, the Medical Research Council and Alzheimer’s Research UK, the institute is bringing new laboratories, equipment and researchers into the fight against dementia at an unprecedented scale. Meanwhile, our Centres of Excellence are transforming research into the best dementia care and support. We’ve also led in the development of a roadmap to make sure that care research is prioritised nationally, alongside finding a cure. We know that investments in research pay off. To give just one example, our research fellows made genetic discoveries this year that fundamentally advance our understanding of dementia, bringing personalised medicine ever closer. There are many individual successes to celebrate, but what excites me most is the unique ability of Alzheimer’s Society to unite people who care about dementia, working across all areas to improve people’s lives. In my new role as Chief Policy and Research Officer, I’m bringing people closer together to campaign for research funding, prepare the health and social care system for advances in treatment and diagnosis, and use research insights to improve dementia services.
    [Show full text]
  • Prion Pathology in the Brainstem: Clinical Target Areas in Prion Disease
    PRION PATHOLOGY IN THE BRAINSTEM: CLINICAL TARGET AREAS IN PRION DISEASE A thesis submitted in partial fulfilment for the degree of Doctor of Philosophy to the University College London by Ilaria Mirabile MRC Prion Unit Institute of Neurology University College London 1 Declaration I, Ilaria Mirabile, confirm that the work presented in this thesis is my own. Where information has been derived from other sources, I confirm that this has been indicated in the thesis 2 List of contributions All the procedures described in this thesis were performed by the candidate, with the following exceptions: In vivo procedures Mice breeding, colony maintenance, ear biopsies, prion inoculation, prion symptoms monitoring, mice culling and brain sampling were performed by designated staff at the Prion Unit animal house facility. Prion inocula were prepared by Dr Jonathan Wadsworth. Immunohistochemistry Paraffin embedding and microtome slicing were performed by designated staff in the MRC Prion Unit histology support group. Molecular biology DNA sequencing was performed by Gary Adamson. Cell culture Flow cytometry was performed by Dr Annika Alexopoulou, Dr Sara Monteiro, and Melania Tangari. 3 Acknowledgments I am extremely grateful to all the members of the MRC Prion Unit for their intellectual, practical and moral support. Firstly, I would like to thank my supervisors, Prof. Parmjit Jat, Prof. John Collinge and Prof. Sebastian Brandner for their guidance. I am particularly grateful to Jackie Linehan, Catherine O‘Malley, Caroline Powell and Lorrain Spence in the Histology Core Facility, and to the Prion Unit Animal Facility, for their tremendous hard work. A big thank goes to the members of Prof Parmjit Jat‘s laboratory who welcome me as a second family, to Prof.
    [Show full text]
  • Delivering Novel Therapies in the 21St Century Conference Report Held on 24 – 25 October 2018
    Part of the conference series Breakthrough science and technologies Transforming our future Delivering novel therapies in the 21st century Conference report Held on 24 – 25 October 2018 Supported by AstraZeneca Delivering novel therapies in the 21st century – Conference report 1 Introduction On 24 – 25 October 2018, the Royal Society and the Academy of Medical Sciences hosted a conference on novel medical therapies. The scientific programme for this meeting was developed by Steve Rees (Vice-President Discovery Biology, AstraZeneca), Professor Molly Stevens FREng (Professor of Biomedical Materials and Regenerative Medicine and Research Director for Biomedical Material Science, Imperial College London), and Sir John Skehel FMedSci FRS (Vice-President and Biological Secretary, the Royal Society). Image: Conference attendees networking. Presentations and discussions outlined recent scientific organised through the Royal Society’s Science and Industry advances in therapeutic modalities and delivery, the programme which demonstrates our commitment to integrate infrastructure required to develop novel treatments, and the science and industry at the Society, promote science and its implications of these advances for policy and healthcare value, build relationships and foster translation. delivery. The conference brought together scientists, technologists and experts from across academia, industry, The Academy’s FORUM programme brings together the NHS and public health, to discuss current challenges in industry, academia and the NHS, and the charity, regulatory human medicine, what future medicines will look like and and wider healthcare sectors. It provides an independent how we can prepare for them. platform for leaders from across the life sciences sector to discuss scientific opportunities, technology trends, This conference, supported by AstraZeneca, forms part of a translational challenges and strategic choices in healthcare.
    [Show full text]
  • The Impact of NMR and MRI
    WELLCOME WITNESSES TO TWENTIETH CENTURY MEDICINE _____________________________________________________________________________ MAKING THE HUMAN BODY TRANSPARENT: THE IMPACT OF NUCLEAR MAGNETIC RESONANCE AND MAGNETIC RESONANCE IMAGING _________________________________________________ RESEARCH IN GENERAL PRACTICE __________________________________ DRUGS IN PSYCHIATRIC PRACTICE ______________________ THE MRC COMMON COLD UNIT ____________________________________ WITNESS SEMINAR TRANSCRIPTS EDITED BY: E M TANSEY D A CHRISTIE L A REYNOLDS Volume Two – September 1998 ©The Trustee of the Wellcome Trust, London, 1998 First published by the Wellcome Trust, 1998 Occasional Publication no. 6, 1998 The Wellcome Trust is a registered charity, no. 210183. ISBN 978 186983 539 1 All volumes are freely available online at www.history.qmul.ac.uk/research/modbiomed/wellcome_witnesses/ Please cite as : Tansey E M, Christie D A, Reynolds L A. (eds) (1998) Wellcome Witnesses to Twentieth Century Medicine, vol. 2. London: Wellcome Trust. Key Front cover photographs, L to R from the top: Professor Sir Godfrey Hounsfield, speaking (NMR) Professor Robert Steiner, Professor Sir Martin Wood, Professor Sir Rex Richards (NMR) Dr Alan Broadhurst, Dr David Healy (Psy) Dr James Lovelock, Mrs Betty Porterfield (CCU) Professor Alec Jenner (Psy) Professor David Hannay (GPs) Dr Donna Chaproniere (CCU) Professor Merton Sandler (Psy) Professor George Radda (NMR) Mr Keith (Tom) Thompson (CCU) Back cover photographs, L to R, from the top: Professor Hannah Steinberg, Professor
    [Show full text]
  • SACN Annual Report 2020
    Annual Report 2020 Published February 2021 ©Crown copyright 2021 SACN’s webpage is available at: www.gov.uk/government/groups/scientific-advisory-committee-on-nutrition Contents Foreword ................................................................................................................... 1 About the committee ................................................................................................ 3 Openness................................................................................................................ 3 Membership ............................................................................................................ 3 Remuneration and committee finance .................................................................... 3 Declaration of interests ........................................................................................... 3 Procedures .............................................................................................................. 4 SACN’s work in 2020 ................................................................................................ 5 Work programme .................................................................................................... 5 Horizon scanning .................................................................................................... 5 Watching brief ......................................................................................................... 6 SACN’s working groups and subgroup ................................................................
    [Show full text]
  • Staff Changes Emma Bennett Joined the Academy As Exhibits Regularly in the UK and Europe
    Council Election Nobel Prize Congratulations to the following Fellows who Dr Sydney Brenner were elected to serve as new members of FRS HonFMedSci was awarded The Council with effect from 21 November 2002. Nobel Prize in Physiology or Medicine for 2002 for his research into genetic regulation of organ development and Professor Carol Black programmed cell death. Though now based in California, President, The Royal College of Physicians and Professor of Sydney Brenner’s discoveries whilst working in Cambridge, Rheumatology, Royal Free and University College Medical School UK, laid the foundation for this year’s prize which was awarded jointly to H Robert Horvitz and John E Sulston. Professor Nancy Rothwell MRC Research Professor, University of Manchester Professor Julia Goodfellow Chief Executive, the Biotechnology and Biological Sciences Research Council Professor Colin Bird Sir Douglas Black Formerly Dean of Medicine and Provost of Faculty Group of Medical and Veterinary Medicine, University of Edinburgh Sir Douglas Black: died September 13, 2002. It is with Medical School much sadness that we record the passing of a distinguished Honorary Fellow. The Black report was widely Professor Jonathan Cohen regarded as the most authoritative publication on the link Dean, Brighton & Sussex Medical School between poor health and social deprivation. That it became Professor Thomas Kirkwood so influential was at least in part due to the then Professor of Medicine, University of Newcastle Upon Tyne Government’s efforts to suppress its publication. Council is pleased to announce the appointment of Sir John Skehel, Sir Douglas was a widely respected and much loved FRS FMedSci, as Shadow Vice-President with responsibility for Professor of Medicine at Manchester and later President of non-clinical affairs.
    [Show full text]
  • Milk and Milk Products in Human Nutrition
    Milk and Milk Products in Human Nutrition Nestlé Nutrition Institute Workshop Series Pediatric Program, Vol. 67 Milk and Milk Products in Human Nutrition Editors Roger A. Clemens, Los Angeles, CA, USA Olle Hernell, Umeå, Sweden Kim Fleischer Michaelsen, Copenhagen, Denmark Nestec Ltd., 55 Avenue Nestlé, CH–1800 Vevey (Switzerland) S. Karger AG, P.O. Box, CH–4009 Basel (Switzerland) www.karger.com © 2011 Nestec Ltd., Vevey (Switzerland) and S. Karger AG, Basel (Switzerland). All rights reserved. This book is protected by copyright. No part of it may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, or recording, or otherwise, without the written permission of the publisher. Printed in Switzerland on acid-free and non-aging paper (ISO 9706) by Reinhardt Druck, Basel ISBN 978–3–8055–9586–5 e-ISBN 978–3–8055–9587–2 ISSN 1661–6677 Library of Congress Cataloging-in-Publication Data Nestlé Nutrition Workshop (67th : 2010 : Marrakech, Morocco) Milk and milk products in human nutrition / editors, Roger A. Clemens, Olle Hernell, Kim Fleischer Michaelsen. p. ; cm. – (Nestlé Nutrition Institute workshop series, pediatric program ; ISSN 1661-6677, v. 67) Includes bibliographical references and index. ISBN 978-3-8055-9586-5 (hard cover : alk. paper) -- ISBN 978-3-8055-9587-2 (e-ISBN) 1. Milk in human nutrition--Congresses. I. Clemens, Roger A. II. Hernell, Olle. III. Michaelsen, Kim Fleischer. IV. Nestlé Nutrition Institute. V. Title. VI. Series: Nestlé Nutrition workshop series. Paediatric programme, v. 67. 1661-6677 [DNLM: 1. Milk--Congresses. 2. Child Nutritional Physiological Phenomena--Congresses.
    [Show full text]
  • Cambridge University Reporter Special Number 3
    SPECIAL NO. 3] OFFICERS NUMBER–MICHAELMAS TERM 2000 45 PA RT I I MEMBERS OF UNIVERSITY BODIES NOMINATING AND APPOINTING BODIES: ABBREVIATIONS C University Council CSHSS Council of the School of CST Council of the School of CSAH Council of the School of Humanities and Social Technology Arts and Humanities Sciences FC Finance Committee of the CSBS Council of the School of CSPS Council of the School of Council the Biological Sciences the Physical Sciences GB General Board of the Faculties Faculty Boards etc., as follows: AA Archaeology and ESG Earth Sciences and Mus Music Anthropology Geography OS Oriental Studies AHA Architecture and History HPS History and Philosophy of PC Physics and Chemistry of Art Science, Board of Phil Philosophy Biol Biology Hst History SPS Social and Political Cl Classics Law Law Sciences Div Divinity Math Mathematics Vet Clinical Veterinary Educ Education Med Clinical Medicine Medicine Engg Engineering MML Modern and Medieval X Co-opted, or appointed Engl English Languages by the body concerned EP Economics and Politics SEPTEMVIRI Prof. A. W.Cuthbert, F, Prof. P. Goddard, JN, Lady Perry, LC, ; Prof. J. H. Baker, CTH,(Chairman) , Dr C. H. Kelsey, G, Prof. Dame Gillian Beer, CLH, Prof. W.A. Brown, DAR, . COURT OF DISCIPLINE To Dec. Panel (a) Panel (b) Panel (c) Prof. W.R. Cornish, M Dr Y.M. Cripps, EM Ms H. E. Bromley, G Lord Goodhart, T, Chairman Dr J. C. D. Hickson, PEM Mr L. J. Burnett, F Mr A. D. Lemons, HH Ms U. Clifford, CL Dr R. C. Love, R Mr B. P.Corlett, JN Dr G.
    [Show full text]
  • BIOLOGY 639 SCIENCE ONLINE the Unexpected Brains Behind Blood Vessel Growth 641 THIS WEEK in SCIENCE 668 U.K
    4 February 2005 Vol. 307 No. 5710 Pages 629–796 $10 07%.'+%#%+& 2416'+0(70%6+10 37#06+6#6+8' 51(69#4' #/2.+(+%#6+10 %'..$+1.1); %.10+0) /+%41#44#;5 #0#.;5+5 #0#.;5+5 2%4 51.76+105 Finish first with a superior species. 50% faster real-time results with FullVelocity™ QPCR Kits! Our FullVelocity™ master mixes use a novel enzyme species to deliver Superior Performance vs. Taq -Based Reagents FullVelocity™ Taq -Based real-time results faster than conventional reagents. With a simple change Reagent Kits Reagent Kits Enzyme species High-speed Thermus to the thermal profile on your existing real-time PCR system, the archaeal Fast time to results FullVelocity technology provides you high-speed amplification without Enzyme thermostability dUTP incorporation requiring any special equipment or re-optimization. SYBR® Green tolerance Price per reaction $$$ • Fast, economical • Efficient, specific and • Probe and SYBR® results sensitive Green chemistries Need More Information? Give Us A Call: Ask Us About These Great Products: Stratagene USA and Canada Stratagene Europe FullVelocity™ QPCR Master Mix* 600561 Order: (800) 424-5444 x3 Order: 00800-7000-7000 FullVelocity™ QRT-PCR Master Mix* 600562 Technical Services: (800) 894-1304 Technical Services: 00800-7400-7400 FullVelocity™ SYBR® Green QPCR Master Mix 600581 FullVelocity™ SYBR® Green QRT-PCR Master Mix 600582 Stratagene Japan K.K. *U.S. Patent Nos. 6,528,254, 6,548,250, and patents pending. Order: 03-5159-2060 Purchase of these products is accompanied by a license to use them in the Polymerase Chain Reaction (PCR) Technical Services: 03-5159-2070 process in conjunction with a thermal cycler whose use in the automated performance of the PCR process is YYYUVTCVCIGPGEQO covered by the up-front license fee, either by payment to Applied Biosystems or as purchased, i.e., an authorized thermal cycler.
    [Show full text]